Canurta's Journal

A collection of news, education, and thought leadership

Canurta Launches ‘The Healing Project’ NFT to Support Decentralized Research & Innovation of Novel Polyphenols

Categorised in: News

04/21/2022

Canurta Inc., the pioneering company behind patent-pending technologies and formulations that fight inflammation at the source, presents ‘The Healing Project’, a collection of Utility NFTs that leverage IP and blockchain technology to advance the development of safe and natural solutions for chronic disease. “By pairing NFTs and health research, there is an exciting opportunity to…

View Article

University of Guelph Researchers Join Canurta, Publish New Findings on Bibenzyl Synthesis

Categorised in: News

03/01/2022

Canurta Inc., the pioneering company behind patent-pending hemp technologies and formulations that are scientifically proven to target inflammation at the source, is pleased to announce the addition of University of Guelph researchers Dr. Kelly Boddington, Ph.D. and Dr. Eric Soubeyrand, Ph.D. to the team to scale up Canurta’s ability to biosynthetically produce rare hemp polyphenols….

View Article

Canurta Announces Partnership with Applied Pharmaceutical Innovation (API) and Dr. Neal M. Davies of University of Alberta

Categorised in: News

02/03/2022

Canurta Inc., the pioneering company behind patent-pending hemp technologies and formulations that targets inflammation at the source has formed a multi-year strategic partnership with Applied Pharmaceutical Innovation (API), a non-profit life sciences institute and Dr. Neal M. Davies, BSc(Pharm), PhD., R.Ph.FCAHS of University of Alberta’s Faculty of Pharmacy and Pharmaceutical Sciences and cofounder of API….

View Article

Renowned Researcher Ethan Russo, MD, Has Joined Canurta as Senior Medical Advisor & Licenses IP

Categorised in: News

01/11/2022

CanurtaTM, the pioneering brand behind patent-pending hemp technologies and formulations that fight inflammation at the source, is pleased to announce that Ethan Russo, MD, the preeminent global medical Cannabis expert, has joined the executive team as Senior Medical Advisor and will provide an exclusive license to related IP through his company CReDO Science, LLC. “Our…

View Article

Letter from our CEO: 2022 Canurta Outlook

01/04/2022

At Canurta we’re extremely proud of our achievements last year, from growing our team and production capabilities, to launching groundbreaking technologies, forming new partnerships and beta-testing our solutions for inflammation. Yet it’s not the last year that excites us most, it’s the next. Our products are set to launch in 2022. Building a business is…

View Article

The Opioid Crisis: Where are the Safer, Natural Alternatives?

12/22/2021

The opioid crisis has reached alarming levels in Canada and the US, driven by both illegal and prescription opioids. There were 24,626 apparent opioid toxicity deaths between January 2016 and June 2021 (Public Health Agency of Canada, 2021), a number greater than the number of Canadians killed daily in motor vehicle collisions since 2015 (Belzak…

View Article